Post-market Clinical Trial of the Dominus® Stent-Graft
ConditionThoracic Aortic Dissection
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorBraile Biomedica Ind. Com. e Repr. Ltda.
About this trial
Real-world clinical trial evidence post-market, evaluating the safety and efficacy of the Dominus® StentGraft Endoprosthesis in treating thoracic aortic diseases, following the Instructions for Use
Eligibility criteria
Qualifiers
18 years of age or older;
Patients treated with the Dominus® Stent-Graft Endoprosthesis in accordance with its Instructions for Use;
Patient available for appropriate follow-up times for the study duration;
Informed patient about the nature of the study, agreeing to its provisions, and signing the informed consent.
Disqualifiers
Patient currently participating in another clinical study of drug or medical device;
Life expectancy less than 12 months.
Trial design
Treatments tested in this trial
- Stent-Graft Dominus® Endoprosthesis
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov